[Editorial] LRRK2 and the new era of Parkinson’s disease research
2017 will mark 200 years since the publication of James Parkinson's An essay on the shaking palsy. As the movement disorders community prepares to commemorate this special anniversary, and celebrates accomplishments in symptomatic treatment over two centuries, a new era of Parkinson's disease research is emerging. The integration of big data sets is paving the way for accelerated discoveries that should lead to drugs that halt disease progression, with genetics as the foundation of therapeutic discovery.
Ander nieuws
[Comment] A new step towards targeting tau
Progressive supranuclear palsy is a rare neurodegenerative disease characterised by an axial parkins...
[Review] CSF and blood biomarkers for Parkinson’s disease
In the management of Parkinson's disease, reliable diagnostic and prognostic biomarkers are urg...
Parkinson’s disease patient: ‘I can walk… it’s really helped me’
Parkinson's disease patient Gail Jardine can walk more freely after having a spinal implant fit...